[HTML][HTML] HBV reactivation during the treatment of non-Hodgkin lymphoma and management strategies

X Cao, Y Wang, P Li, W Huang, X Lu, H Lu - Frontiers in Oncology, 2021 - frontiersin.org
Hepatitis B virus reactivation (HBV-R), which can lead to HBV-related morbidity and
mortality, is a common and well-known complication that occurs during the treatment of non …

Hepatitis B reactivation in the treatment of non-Hodgkin lymphoma

M Kelling, L Sokol, S Dalia - Cancer Control, 2018 - journals.sagepub.com
Chronic active hepatitis B infection (HBV) has been implicated in lymphomagenesis of non-
Hodgkin lymphoma (NHL). Treatment of cancer including NHL with chemotherapy or …

High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China

C Wang, B Xia, Q Ning, H Zhao, H Yang, Z Zhao… - Annals of …, 2018 - Springer
We retrospectively analyzed a large study to investigate the association of hepatitis B virus
(HBV) with aggressive B cell non-Hodgkin's lymphoma (aggressive B-NHL) in China, where …

Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018–2022): A real‐world, retrospective study

Z Li, W Guo, Y Zhao, H Wang, J Guo, Z Li… - Cancer …, 2024 - Wiley Online Library
Objective Recent studies have found a high prevalence of hepatitis B virus (HBV) infection in
patients with non‐Hodgkin's lymphoma (NHL), especially B‐cell non‐Hodgkin's lymphoma …

Hepatitis B virus reactivation: overview and management

W Huang, L Du, H Tang - Future Virology, 2021 - Taylor & Francis
Hepatitis B virus (HBV) can hide in the liver in the form of covalently closed circular DNA.
When the body's immunity changes, HBV reactivation (HBV-R) can occur. The risk of HBV-R …

Bursa Uludağ Üniversitesi Sağlık Uygulama ve Araştırma Merkezi'nde immünsüpresif tedavi nedenli hepatit B reaktivasyon riski olan hastalarda profilaktik tenofovir …

ST Aydın - 2022 - search.proquest.com
Hepatit B virüsü (HBV) ile enfekte olmuş bireyler immünsüpresif veya antikanser tedavileri
aldıklarında HBV reaktivasyonu (HBVr) riski artmaktadır. HBV reaktivasyonu ciddi morbidite …

[HTML][HTML] Long-Term Safety of Rituximab in DLBCL Patients With Hepatitis B-Related Cirrhosis: A Retrospective Case Series

Z Song, Y Ma, D Jiang, R Zhao, F Dong - Frontiers in Medicine, 2022 - frontiersin.org
Objective Chemotherapy regimens containing rituximab (RTX) have been extensively used
to treat diffuse large B cell lymphoma (DLBCL). However, data looking at long-term safety of …